MARKET

SRTS

SRTS

Sensus Hlthcr
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.640
+0.020
+0.55%
Opening 10:51 04/23 EDT
OPEN
3.620
PREV CLOSE
3.620
HIGH
3.640
LOW
3.560
VOLUME
1.82K
TURNOVER
--
52 WEEK HIGH
6.09
52 WEEK LOW
1.760
MARKET CAP
60.01M
P/E (TTM)
-8.7416
1D
5D
1M
3M
1Y
5Y
Sensus Healthcare Reports Sale, Installation Of Its 500th Unit
Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today
Benzinga · 04/13 12:13
Sensus Healthcare Announces the Sale/Install of its 500th Unit
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced the installation of its 500 un...
GlobeNewswire · 04/13 12:00
Colorado State University, Flint Animal Cancer Center Applies Sensus Healthcare's SRT Non-Surgical Treatment to Animal Care
GlobeNewswire · 03/16 12:00
Sensus Healthcare Shares Tick Higher; Co Granted U.S. Patent Titled 'Systems and methods for real time beam sculpting intra-operative-radiation-therapy treatment planning'
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=10940334&OS=10940334&RS=10940334
Benzinga · 03/09 20:33
Sensus Healthcare to Participate in Three Investment Conferences During the Month of March
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced that Joe Sardano, Chai...
GlobeNewswire · 03/08 21:15
10-K: SENSUS HEALTHCARE, INC.
(EDGAR Online via COMTEX) -- Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS You should read the following...
Edgar Online - (EDG = 10Q, 10K) · 03/05 18:00
Sensus Healthcare, Inc. (NASDAQ:SRTS): Are Analysts Optimistic?
Simply Wall St. · 03/02 10:58
Athenex, Xtant Medical among major healthcare premarket losers' pack
Athenex ATNX -55% on Q4 earnings release and on FDA rejection of oral paclitaxel application in breast cancer.Xtant Medical Holdings (XTNT) -16%.PLx Pharma PLXP -9% after FDA OKs PLx Pharma's Vazalore applications.Lixte Biotechnology Holdings (LIXT) -12%.A...
Seekingalpha · 03/01 13:20
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SRTS. Analyze the recent business situations of Sensus Hlthcr through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SRTS stock price target is 6.71 with a high estimate of 7.75 and a low estimate of 6.00.
EPS
Institutional Holdings
Institutions: 26
Institutional Holdings: 1.63M
% Owned: 9.87%
Shares Outstanding: 16.49M
TypeInstitutionsShares
Increased
6
101.55K
New
1
2.00K
Decreased
4
46.43K
Sold Out
4
12.47K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.88%
Healthcare Equipment & Supplies
+0.68%
Key Executives
Chairman/President/Chief Executive Officer/Co-Founder/Director
Joseph Sardano
Co-Founder/Executive Vice President
Stephen Cohen
Chief Financial Officer
Javier Rampolla
Chief Operating Officer
Nicolas Soro
Chief Technology Officer
James Price
Vice President/General Counsel
Michael Sardano
Vice President/Director of Sales
Hoi-Bun Suen
Director
Megan Cornish
Non-Executive Director
Anthony Petrelli
Non-Executive Independent Director
John Heinrich
Non-Executive Independent Director
William McCall
Non-Executive Independent Director
Samuel O'Rear
No Data
  • All
  • Financials
  • Insiders
More
About SRTS
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. It uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100 Plus and SRT-100 Vision. The Company's product, the SRT-100, is a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions, such as keloids. The SRT-100 treats primary lesions in the sensitive areas of the head and neck region. Its Sensus Laser Aesthetic Solutions division provides a range of in-office aesthetic dermatology procedures including facial rejuvenation, wrinkle removal, body sculpting/fat removal as well as other aesthetic applications.

Webull offers kinds of Sensus Healthcare Inc stock information, including NASDAQ:SRTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRTS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRTS stock methods without spending real money on the virtual paper trading platform.